Five Star Equities Issues New Research Reports on ESI, NUS, PANW and STJ


Follow this company

Companies Mentioned

NYSE:ESI / NYSE:NUS / NYSE:PANW / NYSE:STJ
03/25/2014 [ACCESSWIRE]

Five Star Equities releases regular market updates so investors can stay ahead of the crowd and make the best investment decisions to maximize their returns. Take a few minutes to register with us free at www.FiveStarEquities.com and get exclusive access to our numerous stock reports.

ITT Educational Services, Inc. (NYSE: ESI) shares dropped 7.48 percent to close at $27.71 a share Monday. The stock traded between $27.50 and $29.52 on volume of 658,295 shares traded. The company announced that it did not file its Annual Report on Form 10-K for the fiscal year ended December 31, 2013 before the extended due date. Shares of ITT Educational Services are down approximately 17.0 percent year-to-date.

Get more information on ITT Educational Services and free access to the in-depth equity report at:  
www.FiveStarEquities.com/ESI

Nu Skin Enterprises, Inc. (NYSE: NUS) shares surged 18.21 percent to close at $88.66 a share Monday. The stock traded between $86.26 and $97.49 on volume 10.65 million shares traded. Chinese regulators have fined the company $540,000 for its questionable sales and promotional practices, which was significantly lower than expected. Shares of Nu Skin Enterprises are down approximately 35.0 percent year-to-date.

Get more information on Nu Skin Enterprises and free access to the in-depth equity report at:  
www.FiveStarEquities.com/NUS

Palo Alto Networks Inc. (NYSE: PANW) shares fell 4.48 percent to close at $73.13 a share Monday. The stock traded between $71.27 and $77.99 on volume of 2.17 million shares traded. The company announced that it has agreed to acquire Cyvera, a private cyber security company based in Tel-Aviv, Israel, for approximately $200.0 million. Shares of Palo Alto Networks are up approximately 27.0 percent year-to-date.

Get more information on Palo Alto Networks and free access to the in-depth equity report at:  
www.FiveStarEquities.com/PANW

St. Jude Medical, Inc. (NYSE: STJ) shares declined 0.17 percent to close at $65.51 a share Monday. The stock traded between $64.71 and $67.13 on volume 1.92 million shares traded. The company announced that the FDA has granted approval to three of its pacemakers: the Allure Quadra, as well as the Assurity and Endurity. Shares of St. Jude Medical are up approximately 5.0 percent year-to-date.

Get more information on St. Jude Medical free access to the in-depth equity report at:  
www.FiveStarEquities.com/STJ

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Five Star Equities has no financial relationship with any company whose stock is mentioned in this release.

Contact:               
Five Star Equities
info@fivestarequities.com

COMMENTS

Leave a comment...
 * 

Your Name
 *